BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36482487)

  • 1. CRAG: de novo characterization of cell-free DNA fragmentation hotspots in plasma whole-genome sequencing.
    Zhou X; Zheng H; Fu H; Dillehay McKillip KL; Pinney SM; Liu Y
    Genome Med; 2022 Dec; 14(1):138. PubMed ID: 36482487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin.
    Sun K; Jiang P; Cheng SH; Cheng THT; Wong J; Wong VWS; Ng SSM; Ma BBY; Leung TY; Chan SL; Mok TSK; Lai PBS; Chan HLY; Sun H; Chan KCA; Chiu RWK; Lo YMD
    Genome Res; 2019 Mar; 29(3):418-427. PubMed ID: 30808726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OCRDetector: Accurately Detecting Open Chromatin Regions via Plasma Cell-Free DNA Sequencing Data.
    Wang J; Chen L; Zhang X; Tong Y; Zheng T
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq).
    Liu X; Ren J; Luo N; Guo H; Zheng Y; Li J; Tang F; Wen L; Peng J
    Clin Epigenetics; 2019 Jun; 11(1):93. PubMed ID: 31234922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Practical stability of whole-genome bisulfite sequencing using plasma cell-free DNA].
    Fang H; Zhong B; Wei L; Zhang X; Zhang W; Wang X
    Sheng Wu Gong Cheng Xue Bao; 2019 Dec; 35(12):2284-2294. PubMed ID: 31880136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide repeat landscapes in cancer and cell-free DNA.
    Annapragada AV; Niknafs N; White JR; Bruhm DC; Cherry C; Medina JE; Adleff V; Hruban C; Mathios D; Foda ZH; Phallen J; Scharpf RB; Velculescu VE
    Sci Transl Med; 2024 Mar; 16(738):eadj9283. PubMed ID: 38478628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
    Zhang H; Dong P; Guo S; Tao C; Chen W; Zhao W; Wang J; Cheung R; Villanueva A; Fan J; Ding H; Schrodi SJ; Zhang D; Zeng C
    BMC Med; 2020 Aug; 18(1):200. PubMed ID: 32741373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inferring gene expression from cell-free DNA fragmentation profiles.
    Esfahani MS; Hamilton EG; Mehrmohamadi M; Nabet BY; Alig SK; King DA; Steen CB; Macaulay CW; Schultz A; Nesselbush MC; Soo J; Schroers-Martin JG; Chen B; Binkley MS; Stehr H; Chabon JJ; Sworder BJ; Hui AB; Frank MJ; Moding EJ; Liu CL; Newman AM; Isbell JM; Rudin CM; Li BT; Kurtz DM; Diehn M; Alizadeh AA
    Nat Biotechnol; 2022 Apr; 40(4):585-597. PubMed ID: 35361996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients.
    Hallermayr A; Wohlfrom T; Steinke-Lange V; Benet-Pagès A; Scharf F; Heitzer E; Mansmann U; Haberl C; de Wit M; Vogelsang H; Rentsch M; Holinski-Feder E; Pickl JMA
    J Hematol Oncol; 2022 Sep; 15(1):125. PubMed ID: 36056434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FinaleDB: a browser and database of cell-free DNA fragmentation patterns.
    Zheng H; Zhu MS; Liu Y
    Bioinformatics; 2021 Aug; 37(16):2502-2503. PubMed ID: 33258919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Preanalytical and Physiological Variables on Cell-Free DNA Fragmentation.
    van der Pol Y; Moldovan N; Verkuijlen S; Ramaker J; Boers D; Onstenk W; de Rooij J; Bahce I; Pegtel DM; Mouliere F
    Clin Chem; 2022 Jun; 68(6):803-813. PubMed ID: 35292813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Noninvasive Prenatal Diagnosis of De Novo Mutations.
    Peretz-Machluf R; Rabinowitz T; Shomron N
    Methods Mol Biol; 2021; 2243():249-269. PubMed ID: 33606261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclease deficiencies alter plasma cell-free DNA methylation profiles.
    Han DSC; Ni M; Chan RWY; Wong DKL; Hiraki LT; Volpi S; Jiang P; Lui KO; Chan KCA; Chiu RWK; Lo YMD
    Genome Res; 2021 Nov; 31(11):2008-2021. PubMed ID: 34470801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide cell-free DNA fragmentation in patients with cancer.
    Cristiano S; Leal A; Phallen J; Fiksel J; Adleff V; Bruhm DC; Jensen SØ; Medina JE; Hruban C; White JR; Palsgrove DN; Niknafs N; Anagnostou V; Forde P; Naidoo J; Marrone K; Brahmer J; Woodward BD; Husain H; van Rooijen KL; Ørntoft MW; Madsen AH; van de Velde CJH; Verheij M; Cats A; Punt CJA; Vink GR; van Grieken NCT; Koopman M; Fijneman RJA; Johansen JS; Nielsen HJ; Meijer GA; Andersen CL; Scharpf RB; Velculescu VE
    Nature; 2019 Jun; 570(7761):385-389. PubMed ID: 31142840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma.
    Raman L; Van der Linden M; Van der Eecken K; Vermaelen K; Demedts I; Surmont V; Himpe U; Dedeurwaerdere F; Ferdinande L; Lievens Y; Claes K; Menten B; Van Dorpe J
    Genome Med; 2020 Apr; 12(1):35. PubMed ID: 32317009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies.
    Gao Q; Lin YP; Li BS; Wang GQ; Dong LQ; Shen BY; Lou WH; Wu WC; Ge D; Zhu QL; Xu Y; Xu JM; Chang WJ; Lan P; Zhou PH; He MJ; Qiao GB; Chuai SK; Zang RY; Shi TY; Tan LJ; Yin J; Zeng Q; Su XF; Wang ZD; Zhao XQ; Nian WQ; Zhang S; Zhou J; Cai SL; Zhang ZH; Fan J
    Ann Oncol; 2023 May; 34(5):486-495. PubMed ID: 36849097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Read Count Patterns and Detection of Cancerous Copy Number Alterations in Plasma Cell-Free DNA Whole Exome Sequencing Data for Advanced Non-Small Cell Lung Cancer.
    Jang H; Choi CM; Lee SH; Lee S; Jeong MK
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of recurrently protected genomic regions in cell-free DNA found in urine.
    Markus H; Zhao J; Contente-Cuomo T; Stephens MD; Raupach E; Odenheimer-Bergman A; Connor S; McDonald BR; Moore B; Hutchins E; McGilvrey M; de la Maza MC; Van Keuren-Jensen K; Pirrotte P; Goel A; Becerra C; Von Hoff DD; Celinski SA; Hingorani P; Murtaza M
    Sci Transl Med; 2021 Feb; 13(581):. PubMed ID: 33597261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted next-generation sequencing of 50 cancer-related genes in Japanese patients with oral squamous cell carcinoma.
    Nakagaki T; Tamura M; Kobashi K; Omori A; Koyama R; Idogawa M; Ogi K; Hiratsuka H; Tokino T; Sasaki Y
    Tumour Biol; 2018 Sep; 40(9):1010428318800180. PubMed ID: 30226113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-Free DNA Provides a Good Representation of the Tumor Genome Despite Its Biased Fragmentation Patterns.
    Ma X; Zhu L; Wu X; Bao H; Wang X; Chang Z; Shao YW; Wang Z
    PLoS One; 2017; 12(1):e0169231. PubMed ID: 28046008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.